Skip to content

Adjuvant radiotherapy method in breast cancer.

Comparison of short term results of IORT boost and hypofractionated EBRT after BCS with conventional whole breast radiotherapy and external boost in early breast cancers from 2019 to 2020

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180919041070N2
Enrollment
68
Registered
2019-12-03
Start date
2019-11-16
Completion date
Unknown
Last updated
2019-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer. Malignant neoplasm of breast

Interventions

Intervention 1: Intervention group: In hypofractionated radiotherapy group, during breast conservation surgery, patients will receive intraoperative electron radiation therapy with 10 gray dose. Posto

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
35 Years to 60 Years

Inclusion criteria

Inclusion criteria: Definitive diagnosis of breast cancer on pathological examination Age more than 35 year old Tumor size equal and less than 5 centimeter No regional nodal involvement or involvement of equal and less than 3 nodes in post surgical pathological examination Clear surgical margin in post surgical pathological examination

Exclusion criteria

Exclusion criteria: Presence of in-situ carcinoma without invasive component Tumoral adhesion to muscles of the chest wall Inflammatory carcinoma karnofsky performance status less than 70% Previous history of the chest wall irradiation Multiple tumoral masses with more than 5 centimeter distance A history of connective tissue diseases including lupus disease and scleroderma Previous chronic pulmonary disease including pulmonary fibrosis, grade III chronic obstructive pulmonary disease and asthma Distant metastasis large breast based on planning target volume in radiotherapy more than 2500 mililiter Pregnancy

Design outcomes

Primary

MeasureTime frame
Skin complication of radiotherapy. Timepoint: After the third week of radiotherapy and one year after the completion of radiotherapy. Method of measurement: National Cancer Institute Common Terminology Criteria for Adverse Events version 2.0.;Cosmotic outcome. Timepoint: [ne year after the completion of radiotherapy. Method of measurement: Objective Measurement of Cosmetic Outcomes.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactPedram Fadavi

Iran University of Medical Sciences

Fadavi.p@iums.ac.ir+98 21 5522 8584

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 15, 2026